| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 |
NewAmsterdam Pharma Company NV
NAMS
|
BUY |
$45.00
Est. +51%
|
$29.74 | $32.63 |
Pending
|
$26.67
-10.3%
|
| Apr 20, 2026 |
Amphastar Pharmaceuticals Inc
AMPH
|
SELL |
$22.00
Est. +4%
|
$22.92 | $16.65 (Low) |
Target Met
|
$20.18
+12.0%
|
| Mar 13, 2026 |
Mineralys Therapeutics Inc
MLYS
|
BUY |
$30.00
Est. +14%
|
$26.23 | $32.05 |
Target Met
|
$26.09
-0.5%
|
| Mar 03, 2026 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$125.00
Est. +40%
|
$89.56 | $119.75 |
Pending
|
$116.02
+29.5%
|
| Mar 03, 2026 |
SpyGlass Pharma, Inc. Common Stock
SGP
|
BUY |
$62.00
Est. +132%
|
$26.73 | $26.00 |
Pending
|
$25.17
-5.8%
|
| Jan 22, 2026 |
Amicus Therapeutics Inc
FOLD
|
BUY |
$14.50
Est. +1%
|
$14.35 | $14.50 |
Bullseye Hit (±1%)
|
$14.49
+1.0%
|
| Jan 02, 2025 |
Ardelyx Inc
ARDX
|
BUY |
$8.00
Est. +56%
|
$5.12 | $6.78 |
Miss
|
$3.91
-23.6%
|
| Jan 01, 2025 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$80.00
Est. +43%
|
$55.98 | $122.20 |
Target Met
|
$116.02
+107.3%
|
| Nov 08, 2024 |
Inhibikase Therapeutics Inc
IKT
|
BUY |
$8.00
Est. +188%
|
$2.78 | $4.14 |
Miss
|
$2.41
-13.3%
|
| Sep 20, 2024 |
Assembly Biosciences Inc
ASMB
|
BUY |
$35.00
Est. +89%
|
$18.50 | $27.17 |
Miss
|
$29.95
+61.9%
|
| Sep 03, 2024 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX
|
SELL |
$6.00
Est. +0%
|
$6.02 | $3.79 (Low) |
Target Met
|
$3.31
+45.0%
|
| May 07, 2024 |
Lyra Therapeutics Inc
LYRA
|
SELL |
$0.50
Est. +4%
|
$0.52 | $4.10 (Low) |
Miss
|
$0.15
+71.2%
|